Search research articles
Contact Us
Filters
Showing results (1421-1430 of 1,603) with videos related to
Page
of 161
Sort By:
ESMO Open
|
September 6, 2024
Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 study
H S Rugo, M Oliveira, S J Howell, et al.
Journal of Medicinal Chemistry
|
November 15, 2021
Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors
Dennis X Hu, Snahel Patel, Huifen Chen, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
April 30, 2022
[Course of disease and related epidemiological parameters of COVID-19: a prospective study based on contact tracing cohort]
Y Zhou, W J Liang, Z H Chen, et al.
Molecular Cancer Therapeutics
|
August 14, 2020
Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity <i>In Vitro</i> and <i>In Vivo</i>
Yamini M Ohol, Michael T Sun, Gene Cutler, et al.
Circulation Research
|
November 3, 2017
Mitochondrial Reactive Oxygen Species in Lipotoxic Hearts Induce Post-Translational Modifications of AKAP121, DRP1, and OPA1 That Promote Mitochondrial Fission
Kensuke Tsushima, Heiko Bugger, Adam R Wende, et al.
ESMO Open
|
June 10, 2025
Analytical and clinical validation of PATHWAY HER2 (4B5) assay for assessment of HER2-low/HER2-ultralow status and eligibility for trastuzumab deruxtecan in DESTINY-Breast06
R Shami, R Salgado, A Bardia, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
February 25, 2024
[Epidemiological characteristics of human respiratory syncytial virus among acute respiratory infection cases in 16 provinces of China from 2009 to 2023]
A L Cui, B C Xia, Z Zhu, et al.
The Journal of Hospital Infection
|
March 30, 2024
Epidemiology of healthcare-associated Pseudomonas aeruginosa in intensive care units: are sink drains to blame?
C Volling, L Mataseje, L Graña-Miraglia, et al.
Physical Review. E
|
October 18, 2023
Laser-direct-drive fusion target design with a high-Z gradient-density pusher shell
S X Hu, L Ceurvorst, J L Peebles, et al.
Journal of Medicinal Chemistry
|
July 14, 2026
Discovery of Tivumecirnon (FLX475), a Potent and Selective CCR4 Antagonist That Inhibits the Migration of Immunosuppressive Regulatory T Cells into the Tumor Microenvironment to Restore Antitumor Immunity
Omar Robles, Dirk G Brockstedt, Joel Aponte-Guzman, et al.
Page
of 161
Search research articles
Search
Showing results (1421-1430 of 1,603) with videos related to
Sort By:
Page
of 161
ESMO Open
|
September 6, 2024
Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 study
H S Rugo, M Oliveira, S J Howell, et al.
Journal of Medicinal Chemistry
|
November 15, 2021
Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors
Dennis X Hu, Snahel Patel, Huifen Chen, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
April 30, 2022
[Course of disease and related epidemiological parameters of COVID-19: a prospective study based on contact tracing cohort]
Y Zhou, W J Liang, Z H Chen, et al.
Molecular Cancer Therapeutics
|
August 14, 2020
Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity <i>In Vitro</i> and <i>In Vivo</i>
Yamini M Ohol, Michael T Sun, Gene Cutler, et al.
Circulation Research
|
November 3, 2017
Mitochondrial Reactive Oxygen Species in Lipotoxic Hearts Induce Post-Translational Modifications of AKAP121, DRP1, and OPA1 That Promote Mitochondrial Fission
Kensuke Tsushima, Heiko Bugger, Adam R Wende, et al.
ESMO Open
|
June 10, 2025
Analytical and clinical validation of PATHWAY HER2 (4B5) assay for assessment of HER2-low/HER2-ultralow status and eligibility for trastuzumab deruxtecan in DESTINY-Breast06
R Shami, R Salgado, A Bardia, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
February 25, 2024
[Epidemiological characteristics of human respiratory syncytial virus among acute respiratory infection cases in 16 provinces of China from 2009 to 2023]
A L Cui, B C Xia, Z Zhu, et al.
The Journal of Hospital Infection
|
March 30, 2024
Epidemiology of healthcare-associated Pseudomonas aeruginosa in intensive care units: are sink drains to blame?
C Volling, L Mataseje, L Graña-Miraglia, et al.
Physical Review. E
|
October 18, 2023
Laser-direct-drive fusion target design with a high-Z gradient-density pusher shell
S X Hu, L Ceurvorst, J L Peebles, et al.
Journal of Medicinal Chemistry
|
July 14, 2026
Discovery of Tivumecirnon (FLX475), a Potent and Selective CCR4 Antagonist That Inhibits the Migration of Immunosuppressive Regulatory T Cells into the Tumor Microenvironment to Restore Antitumor Immunity
Omar Robles, Dirk G Brockstedt, Joel Aponte-Guzman, et al.
Page
of 161